Predictmedix Receives Purchase Order Valued at $500k from MGM Healthcare for AI-Powered Safe Entry Stations to Enhance Healthcare...
Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening Toronto...
Predictmedix Announces Production of AI-Powered Mobile Application to Detect Impairment from Alcohol and Cannabis Predictmedix has...
Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry's Medical Device Regulatory Approval in Indonesia The...
Predictmedix Announces a Purchase Order for Safe Entry's Fit for Duty Screening in the Defence Sector DefSpace, a global...
Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at...
TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to announce...
DALLAS, Dec. 27 /PRNewswire/ -- Beacon Equity Research announces the availability of TraderNotes on stocks that are making news...
NEW YORK, Feb. 9 /PRNewswire/ -- On February 7, Ray Cannefax, CEO of Paradigm Medical Industries, Inc. (OTC:PMED) (BULLETIN BOARD: PMED...
Paradigm Medical Third Quarter Net Income $37,000, Sales Increase 32% SALT LAKE CITY, Nov. 17 /PRNewswire-FirstCall/ -- Paradigm Medical...
Support
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads